Ever since Steve Collis became CEO of drug distributor AmerisourceBergen in 2011, shareholders had voted overwhelmingly in favor of how much he got paid.
That changed last week, after a group of investors challenged Collis’ $14.3 million compensation, and 26% raise, given him despite the billions the distributor is preparing to pay to settle nationwide opioid lawsuits.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,